ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,00%
Dow Jones
39 806,77
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,005
-0,63%
Bitcoin
71 167,16
-0,40%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alpha Tau Medical Ltd (DRTS)

  7. Alpha Tau Medical Ltd (DRTS) Actualités

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DRTS
DateHeureSourceTitreSymboleSociété
20/05/202422h01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
13/05/202414h30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSAlpha Tau Medical Ltd
06/05/202414h30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
01/05/202414h30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
25/03/202413h50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422h01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
26/02/202414h30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/12/202315h15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
18/12/202317h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202314h30GlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
28/11/202314h30GlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSAlpha Tau Medical Ltd
20/11/202314h30GlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSAlpha Tau Medical Ltd
16/11/202322h30GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
30/10/202313h30GlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSAlpha Tau Medical Ltd
24/10/202315h00GlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSAlpha Tau Medical Ltd
25/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRTSAlpha Tau Medical Ltd
14/09/202314h30GlobeNewswire Inc.Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterNASDAQ:DRTSAlpha Tau Medical Ltd
11/09/202322h16Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:DRTSAlpha Tau Medical Ltd
28/08/202322h02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
17/08/202323h00GlobeNewswire Inc.Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTNASDAQ:DRTSAlpha Tau Medical Ltd
09/06/202322h47Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DRTSAlpha Tau Medical Ltd
06/06/202315h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRTSAlpha Tau Medical Ltd
24/05/202322h01GlobeNewswire Inc.Alpha Tau Medical to Participate in June Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
23/05/202322h01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
17/05/202322h30GlobeNewswire Inc.Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityNASDAQ:DRTSAlpha Tau Medical Ltd
11/05/202322h00GlobeNewswire Inc.Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenNASDAQ:DRTSAlpha Tau Medical Ltd
03/05/202322h00GlobeNewswire Inc.Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayNASDAQ:DRTSAlpha Tau Medical Ltd
13/04/202314h24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRTSAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTS

Dernières Valeurs Consultées

AMEX
TBJL
Innovator 20 Year Treasu...
KUCN
ELONUSDT
Dogelon
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés